We are live on
!
Find out more
SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
1-Year Est. Return
0.56%
This Fund
S&P 500
This Quarter
Est. Return
-17.71%
1 Year Est. Return
+0.56%
3 Year Est. Return
-0.75%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$504M
AUM Growth
-$396M
(-44%)
Cap. Flow
-$283M
Cap. Flow
% of AUM
-56.16%
Top 10 Holdings %
Top 10 Hldgs %
63.87%
Holding
48
New
7
Increased
17
Reduced
13
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$40M |
| 2 |
Elevance Health
ELV
|
+$27.4M |
| 3 |
SHPG
Shire pic
SHPG
|
+$20.2M |
| 4 |
Labcorp
LH
|
+$14.2M |
| 5 |
LCI
Lannett Company, Inc.
LCI
|
+$7.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$132M |
| 2 |
Viatris
VTRS
|
+$42.5M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$42.4M |
| 4 |
AET
Aetna Inc
AET
|
+$35.9M |
| 5 |
STJ
St Jude Medical
STJ
|
+$31.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 88% |
| 2 | Financials | 4.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACOR
26
DELISTED
Acorda Therapeutics
ACOR
| $4.89M | 0.97% |
1,541
-2,661
| -63% | -$11M |
|
|
LCI
27
DELISTED
Lannett Company, Inc.
LCI
| $4.87M | 0.97% |
+67,900
| New | +$7.19M |
|
|
ARNA
28
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $4.09M | 0.81% |
207,609
+13,200
| +7% | +$212K |
|
29
Eledon Pharmaceuticals
ELDN
$260M
| $3.57M | 0.71% |
+3,933
| New | +$3.86M |
|
30
Rigel Pharmaceuticals
RIGL
$707M
| $3.36M | 0.67% |
161,620
+10,270
| +7% | +$253K |
|
|
VXRT
31
DELISTED
Vaxart
VXRT
| $3.06M | 0.61% |
185,471
+11,791
| +7% | +$210K |
|
|
NDRM
32
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $3.04M | 0.6% |
215,400
+13,700
| +7% | +$185K |
|
|
KDNY
33
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
| $2.74M | 0.54% |
+42,736
| New | +$3.46M |
|
|
AGRX
34
DELISTED
Agile Therapeutics
AGRX
| $2.56M | 0.51% |
206
+13
| +7% | +$168K |
|
|
ZGNX
35
DELISTED
Zogenix, Inc.
ZGNX
| $2.48M | 0.49% |
268,600
-109,000
| -29% | -$1.09M |
|
|
SIEN
36
DELISTED
Sientra, Inc.
SIEN
| $2.15M | 0.43% |
31,407
-26,678
| -46% | -$2.01M |
|
|
ADYX
37
DELISTED
Adynxx Inc
ADYX
| $579K | 0.12% |
11,768
-5,134
| -30% | -$411K |
|
|
AVDL
38
DELISTED
Avadel Pharmaceuticals
AVDL
| – | – |
-441,500
| Closed | -$5.39M |
|
|
39
Bausch Health
BHC
$1.68B
| – | – |
-1,299,056
| Closed | -$132M |
|
40
Biogen
BIIB
$31.7B
| – | – |
-86,300
| Closed | -$26.4M |
|
41
Centene
CNC
$31.3B
| – | – |
-520,000
| Closed | -$17.1M |
|
42
DaVita
DVA
$15.6B
| – | – |
-94,800
| Closed | -$6.61M |
|
|
ESPR
43
DELISTED
Esperion Therapeutics
ESPR
| – | – |
-223,700
| Closed | -$4.98M |
|
|
44
Viatris
VTRS
$20.8B
| – | – |
-785,284
| Closed | -$42.5M |
|
|
FPRX
45
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| – | – |
-135,535
| Closed | -$5.62M |
|
|
MNK
46
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – |
-291,940
| Closed | -$21.8M |
|
|
SPNC
47
DELISTED
Spectranetics Corp
SPNC
| – | – |
-1,092,512
| Closed | -$16.5M |
|
|
STJ
48
DELISTED
St Jude Medical
STJ
| – | – |
-506,900
| Closed | -$31.3M |
|
Similar funds
BCP
PRHC
NAM
GG
SM
BC
SCPM
FAM
Senzar Asset Management's Q1 2016 Portfolio in Review
As of Q1 2016, Senzar Asset Management held 48 positions worth $504M, down 44% from $899M the previous quarter. Its ten largest holdings account for 64% of the portfolio.
Senzar Asset Management withdrew a net $283M in Q1 2016, closing 11 positions and reducing 13 holdings. Its most notable exit was Bausch Health, an estimated $132M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 88% of assets, up from 88% a quarter earlier, followed by Financials.
Against the trend, Senzar Asset Management opened a new position in Amgen worth $40.4M.
- Senzar Asset Management's largest Q1 2016 buy was Amgen: 269,300 shares worth $40.4M.
- Senzar Asset Management added most to Momenta Pharmaceuticals, Inc. in Q1 2016, an estimated $7.08M increase.
- Senzar Asset Management's biggest Q1 2016 reduction was Teva Pharmaceuticals, cutting an estimated $42.4M.
- Senzar Asset Management fully exited Bausch Health in Q1 2016, selling an estimated $132M.
- Senzar Asset Management's ten largest holdings make up 64% of its $504M portfolio in Q1 2016.
- Senzar Asset Management opened 7 new positions and closed 11 in Q1 2016.
- Senzar Asset Management's portfolio value fell 44% quarter-over-quarter to $504M.
Based on Senzar Asset Management's 13F filing for Q1 2016, filed 13 May 2016.